ClearPoint Neuro Inc CLPT Q1 2026 Earnings EPS Misses Estimates by 1478 Amid Operational Investment OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Portfolio Performance Vistagen Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Boosts Investor Sentiment Turn Therapeutics TTRX Q1 2026 Earnings Narrow EPS Miss Amid Modest Stock Gains ATLCP Q1 2026 Earnings Preferred Stock Delivers Significant EPS Surprise ZWS Q1 2026 Earnings EPS Surges Past Estimates with 116 Beat